The University of Chicago Header Logo

Search Result Details

Back to Search Results
This page shows the details of why an item matched the keywords from your search.
Search Results
Hanauer, Stephen
One or more keywords matched the following items that are connected to Hanauer, Stephen
Item TypeName
Concept Aminosalicylic Acid
Concept Mesalamine
Academic Article Mesalamine capsules for the treatment of active Crohn's disease: results of a 16-week trial. Pentasa Crohn's Disease Study Group.
Academic Article Dose-ranging study of mesalamine (PENTASA) enemas in the treatment of acute ulcerative proctosigmoiditis: results of a multicentered placebo-controlled trial. The U.S. PENTASA Enema Study Group.
Academic Article Evolving treatment strategies for inflammatory bowel disease.
Academic Article A meta-analysis and overview of the literature on treatment options for left-sided ulcerative colitis and ulcerative proctitis.
Academic Article Comparative tolerability of treatments for inflammatory bowel disease.
Academic Article Balsalazide led to greater remission rates and tolerance than mesalamine in acute ulcerative colitis.
Academic Article Prevalence of nonadherence with maintenance mesalamine in quiescent ulcerative colitis.
Academic Article Long-term use of mesalamine (Rowasa) suppositories in remission maintenance of ulcerative proctitis.
Academic Article Efficacy and safety of oral ridogrel in the treatment of ulcerative colitis: two multicentre, randomized, double-blind studies.
Academic Article Systematic review: the pharmacokinetic profiles of oral mesalazine formulations and mesalazine pro-drugs used in the management of ulcerative colitis.
Academic Article Mesalamine derivatives in the treatment of Crohn's disease.
Academic Article Oral Pentasa in the treatment of active Crohn's disease: A meta-analysis of double-blind, placebo-controlled trials.
Academic Article Postoperative maintenance of Crohn's disease remission with 6-mercaptopurine, mesalamine, or placebo: a 2-year trial.
Academic Article Medication nonadherence and the outcomes of patients with quiescent ulcerative colitis.
Academic Article Treatment of ulcerative colitis with balsalazide: response to Drs Johnson, Green, and Pruitt.
Academic Article Caution in the interpretation of safety and efficacy differences in clinical trials comparing aminosalicylates for ulcerative colitis.
Academic Article Aminosalicylate therapy in the prevention of dysplasia and colorectal cancer in ulcerative colitis.
Academic Article New lessons: classic treatments, expanding options in ulcerative colitis.
Academic Article Comparative analysis of the in vitro prosecretory effects of balsalazide, sulfasalazine, olsalazine, and mesalamine in rabbit distal ileum.
Academic Article Comparative pharmacokinetics of equimolar doses of 5-aminosalicylate administered as oral mesalamine (Asacol) and balsalazide: a randomized, single-dose, crossover study in healthy volunteers.
Academic Article Review article: evolving concepts in treatment and disease modification in ulcerative colitis.
Academic Article Controversies with aminosalicylates in inflammatory bowel disease.
Academic Article Maintaining remissions across the lifespan: a roundtable discussion with Crohn's disease experts.
Academic Article Aminosalicylates: old and new.
Academic Article Optimizing conventional therapies for inflammatory bowel disease.
Academic Article Aminosalicylates for induction of remission or response in Crohn's disease.
Academic Article Efficacy of topical 5-aminosalicylates in preventing relapse of quiescent ulcerative colitis: a meta-analysis.
Academic Article The case for using 5-aminosalicyclates in Crohn's disease: pro.
Academic Article Safety and efficacy of controlled-release mesalamine for maintenance of remission in ulcerative colitis. Pentasa UC Maintenance Study Group.
Academic Article Delayed-release oral mesalamine at 4.8 g/day (800 mg tablet) for the treatment of moderately active ulcerative colitis: the ASCEND II trial.
Academic Article Delayed-release oral mesalamine 4.8 g/day (800-mg tablet) is effective for patients with moderately active ulcerative colitis.
Academic Article 5-ASA enema therapy.
Academic Article Quality-of-life results of double-blind, placebo-controlled trial of mesalamine in patients with Crohn's disease.
Academic Article Mesalamine capsules for treatment of active ulcerative colitis: results of a controlled trial. Pentasa Study Group.
Academic Article Delayed-release oral mesalamine 4.8 g/day (800 mg tablets) compared to 2.4 g/day (400 mg tablets) for the treatment of mildly to moderately active ulcerative colitis: The ASCEND I trial.
Academic Article Long-term management of Crohn's disease with mesalamine capsules (Pentasa). Pentasa Crohn's Disease Compassionate Use Study Group.
Academic Article Effect of disodium azodisalicylate on electrolyte transport in rabbit ileum and colon in vitro. Comparison with sulfasalazine and 5-aminosalicylic acid.
Academic Article Mesalamine capsules enhance the quality of life for patients with ulcerative colitis.
Academic Article Medical therapy to reduce postoperative Crohn's disease recurrence.
Academic Article The role of mesalazine in Crohn's disease.
Academic Article Review article: high-dose aminosalicylates to induce and maintain remissions in ulcerative colitis.
Academic Article Mea culpa.
Academic Article Early symptomatic response and mucosal healing with mesalazine rectal suspension therapy in active distal ulcerative colitis--additional results from two controlled studies.
Academic Article Comparing guidelines for the treatment of inflammatory bowel disease.
Academic Article Oral or Topical 5-ASA in Ulcerative Colitis.
Academic Article Aminosalicylates for induction of remission or response in Crohn's disease.
Academic Article Too Soon to Discard 5-ASAs?
Academic Article Time to Symptom Resolution in Ulcerative Colitis With Multimatrix Mesalazine Treatment: A Pooled Analysis.
Academic Article MMX Mesalamine for Induction and Maintenance Therapy in Mild-to-Moderate Ulcerative Colitis.
Search Criteria
  • Mesalamine